Difference between revisions of "2011 Group Project 9"

From Embryology
Line 152: Line 152:
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses.

Revision as of 12:35, 7 September 2011

Note - This page is an undergraduate science embryology student group project 2011.
2011 Projects: Turner Syndrome | DiGeorge Syndrome | Klinefelter's Syndrome | Huntington's Disease | Fragile X Syndrome | Tetralogy of Fallot | Angelman Syndrome | Friedreich's Ataxia | Williams-Beuren Syndrome | Duchenne Muscular Dystrolphy | Cleft Palate and Lip

Your Project Goes Here.

2011 Projects: Turner Syndrome | DiGeorge Syndrome | Klinefelter's Syndrome | Huntington's Disease | Fragile X Syndrome | Tetralogy of Fallot | Angelman Syndrome | Friedreich's Ataxia | Williams-Beuren Syndrome | Duchenne Muscular Dystrolphy | Cleft Palate and Lip

Williams-Beuren Syndrome


Williams-Beuren Syndrome, more commonly known as William’s Syndrome, is a congenital anomaly caused by the deletion of 28 neighbouring genes on chromosome 7q11.23.[1] [2]

This multisystem developmental genetic disorder implicates both pre-natal and post-natal physical, psychological, behavioural and medical defects, including diverse phenotypic characteristics such as:

  • distinctive facial deformities
  • cardiovascular abnormalities
  • connective tissue abnormalities
  • intellectual disabilities/mental retardation
  • growth abnormalities
  • endocrine abnormalities
  • a unique personality and cognitive profile [1] [3]

Some or all of these features may be present in varying degrees

History of the disease

William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher. J.C.P Williams was the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of Supravalvular Aortic Stenosis (SAoS), an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. [4] [5]

In 1962 AJ Beuren and associates also studied the correlations between SAoS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. [6] [7] Beuren also noted the behavioural traits of his subjects suffering from SAoS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. [6] [4]

In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SAoS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. [8] [4]


Genetic factors and Etiology

Williams Syndrome is a multi-system genomic disorder that occurs due to a hemizygous deletion/nonallelic homologous recombination (NAHR). The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.[1] [3]

The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats (LCR).The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. [PMID: 20301427] This occurs during the process of meiosis and follows an unequal crossing over that is due to a high similarity of LCRs.

A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. [PMID: 20425789]CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.

In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where autosomal dominant inheritance of Williams syndrome has been reported.


There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:

•Distinctive facial features

•Unique personality

•Intellectual disability

•Growth abnormalities

•Cardiovascular Disease

•Endocrine Abnormalities

Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. [9]

Fluorescent in situ hybridisation (FISH): FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed.

Targeted Mutation Analysis: these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.

•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.

•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.

•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats (STRs) from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.

Physical Characteristics


Facial abnormailities

Skeletal Abnormalities

Cardiac Conditions


Other problems


Renal Tract Abnormalities

18% of people with Williams Syndrome have some form of renal tract abnormality. This includes:

Renal Agenesis

Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively.

Duplicated kidneys

Vesicourinary reflux


Other Abnormalities

There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.[10]



Diabetes Mellitus


Other Associated Medical Conditions

Joint Abnormalities : info

Inguinal Hernias : info

Auditory Abnormalities : [11]

Anxiety Disorders : It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. [12]

Vocal cord paralysis : info

Hoarse Voice : The hoarse voice is present in 98% of people with Williams Syndrome and it is due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres.

Cognitive, Behavioural and Neurological Problems

Speech impairment

Social use of language


Musical ability



Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses.


Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. The treatment of specific WS phenotypes such as hypercalcemia involves constant monitoring of the patients’ blood calcium levels and food intake. 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment of hypercalcemia may include diet modification, oral corticosteroids, and/or intravenous pamidronate.In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise.

Signs and symptoms of hypercalcemia, in addition to blood calcium levels, should be periodically monitored throughout life and prior to the administration of any anesthetic or sedative agent and prior to any invasive procedure. WS patients should restrict the intake of calcium, vitamin D (including vitamin formulations) and specialised formulas to be able to achieve levels in the normal range for correlating age. Bisphosphonates may be required for some patients to control elevated calcium levels.

Rate of Incidence

Williams-Beuren Syndrome occurs in less than 1 in 20,000 births. In the U.S, this figure is slightly more accurate with occurences of 1 in 7,500-20,000 births.

Specialised Facilities and Supportive Associations

Case studies

Interesting facts

Current research and developments


Congenital anomaly:


Nonallelic homozygous recombination(NAHR):




  1. 1.0 1.1 1.2 <pubmed>2042578 </pubmed>
  2. http://omim.org/entry/194050
  3. 3.0 3.1 <pubmed>19568270 </pubmed>
  4. 4.0 4.1 4.2 <pubmed>21120465 </pubmed>
  5. <pubmed>14007182 </pubmed>
  6. 6.0 6.1 <pubmed>13967885 </pubmed>
  7. <pubmed>18941598 </pubmed>
  8. <pubmed>14136289 </pubmed>
  9. <pubmed>7693128 </pubmed>
  10. <pubmed>20425789 </pubmed>
  11. <pubmed>20425785 </pubmed>
  12. <pubmed>20161441 </pubmed>